In this study, we found that deletion of Brca1 enhances the tumor-initiating potential of tumor cells, and that estrogen stimulates proliferation and the tumor-initiating potential of both Brca1-proficient ER-positive and Brca1-deficient ER-negative tumor cells. This evidence concerns the gene BRCA1 and neoplasm.